JP2008501785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008501785A5 JP2008501785A5 JP2007526712A JP2007526712A JP2008501785A5 JP 2008501785 A5 JP2008501785 A5 JP 2008501785A5 JP 2007526712 A JP2007526712 A JP 2007526712A JP 2007526712 A JP2007526712 A JP 2007526712A JP 2008501785 A5 JP2008501785 A5 JP 2008501785A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- tumor
- butoxyiminomethylcamptothecin
- liposome formulation
- oral administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- UIVFUQKYVFCEKJ-OPTOVBNMSA-N gimatecan Chemical compound C1=CC=C2C(\C=N\OC(C)(C)C)=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 UIVFUQKYVFCEKJ-OPTOVBNMSA-N 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 208000025421 tumor of uterus Diseases 0.000 claims 1
- 206010046766 uterine cancer Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000288A ITRM20040288A1 (it) | 2004-06-11 | 2004-06-11 | Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. |
| PCT/IT2005/000320 WO2005120643A2 (en) | 2004-06-11 | 2005-06-08 | Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014165542A Division JP2014231518A (ja) | 2004-06-11 | 2014-08-15 | 子宮腫瘍の治療用医薬の調製のための７−ｔ−ブトキシイミノメチルカンプトテシンの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008501785A JP2008501785A (ja) | 2008-01-24 |
| JP2008501785A5 true JP2008501785A5 (enExample) | 2008-07-17 |
Family
ID=34979678
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007526712A Withdrawn JP2008501785A (ja) | 2004-06-11 | 2005-06-08 | 子宮腫瘍の治療用医薬の調製のための７−ｔ−ブトキシイミノメチルカンプトテシンの使用 |
| JP2014165542A Pending JP2014231518A (ja) | 2004-06-11 | 2014-08-15 | 子宮腫瘍の治療用医薬の調製のための７−ｔ−ブトキシイミノメチルカンプトテシンの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014165542A Pending JP2014231518A (ja) | 2004-06-11 | 2014-08-15 | 子宮腫瘍の治療用医薬の調製のための７−ｔ−ブトキシイミノメチルカンプトテシンの使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7700613B2 (enExample) |
| EP (1) | EP1773451B1 (enExample) |
| JP (2) | JP2008501785A (enExample) |
| KR (1) | KR101221640B1 (enExample) |
| CN (2) | CN1953784A (enExample) |
| AR (1) | AR049220A1 (enExample) |
| AT (1) | ATE521351T1 (enExample) |
| AU (1) | AU2005251573B2 (enExample) |
| BR (1) | BRPI0511931A (enExample) |
| CA (1) | CA2565213C (enExample) |
| CY (1) | CY1112032T1 (enExample) |
| DK (1) | DK1773451T3 (enExample) |
| ES (1) | ES2372056T3 (enExample) |
| HK (1) | HK1205951A1 (enExample) |
| HR (1) | HRP20110718T1 (enExample) |
| IT (1) | ITRM20040288A1 (enExample) |
| MX (1) | MXPA06014162A (enExample) |
| PL (1) | PL1773451T3 (enExample) |
| PT (1) | PT1773451E (enExample) |
| RS (1) | RS52038B (enExample) |
| SI (1) | SI1773451T1 (enExample) |
| TW (1) | TWI351283B (enExample) |
| WO (1) | WO2005120643A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080213385A1 (en) * | 2005-08-10 | 2008-09-04 | Oskar Kalb | Formulations for 7- (T-Butoxy) Iminomethyl Camptothecin |
| AU2008210511A1 (en) * | 2007-02-01 | 2008-08-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Pharmaceutical composition comprising a campothecin derivative |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2757514B1 (fr) * | 1996-12-20 | 1999-02-12 | Sod Conseils Rech Applic | Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant |
| DE69635560T2 (de) * | 1995-06-21 | 2006-08-17 | Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.) | Camptothecinanaloge, Verfahren zur ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen |
| UA57757C2 (uk) * | 1996-12-20 | 2003-07-15 | Сос'Єте Де Консей Де Решерш Е Даплікасьон С'Єнтіфік (С.К.Р.А.С.) | Аналоги камптотецину, спосіб їх отримання (варіанти) і фармацевтична композиція |
| US7105492B2 (en) * | 1999-03-09 | 2006-09-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
| DK1044977T3 (da) | 1999-03-09 | 2002-07-08 | Sigma Tau Ind Farmaceuti | Camptothecinderivater med antitumoraktivitet |
| IT1306129B1 (it) * | 1999-04-13 | 2001-05-30 | Sigma Tau Ind Farmaceuti | Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti |
| US6352996B1 (en) * | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| WO2003043584A2 (en) | 2001-11-20 | 2003-05-30 | University Of Kentucky Research Foundation | Engineered liposomal particles containing core-loaded pro-drugs for the controlled release of camptothecins |
| WO2004103358A2 (en) * | 2003-05-21 | 2004-12-02 | Novartis Ag | Combination of histone deacetylase inhibitors with chemotherapeutic agents |
-
2004
- 2004-06-11 IT IT000288A patent/ITRM20040288A1/it unknown
-
2005
- 2005-05-19 TW TW094116349A patent/TWI351283B/zh not_active IP Right Cessation
- 2005-06-08 AU AU2005251573A patent/AU2005251573B2/en not_active Ceased
- 2005-06-08 PT PT05761294T patent/PT1773451E/pt unknown
- 2005-06-08 CN CNA2005800157280A patent/CN1953784A/zh active Pending
- 2005-06-08 MX MXPA06014162A patent/MXPA06014162A/es active IP Right Grant
- 2005-06-08 PL PL05761294T patent/PL1773451T3/pl unknown
- 2005-06-08 JP JP2007526712A patent/JP2008501785A/ja not_active Withdrawn
- 2005-06-08 DK DK05761294.7T patent/DK1773451T3/da active
- 2005-06-08 US US11/628,458 patent/US7700613B2/en not_active Expired - Fee Related
- 2005-06-08 CN CN201410616189.7A patent/CN104352496A/zh active Pending
- 2005-06-08 CA CA2565213A patent/CA2565213C/en not_active Expired - Fee Related
- 2005-06-08 ES ES05761294T patent/ES2372056T3/es not_active Expired - Lifetime
- 2005-06-08 SI SI200531393T patent/SI1773451T1/sl unknown
- 2005-06-08 AT AT05761294T patent/ATE521351T1/de active
- 2005-06-08 BR BRPI0511931-6A patent/BRPI0511931A/pt active Search and Examination
- 2005-06-08 WO PCT/IT2005/000320 patent/WO2005120643A2/en not_active Ceased
- 2005-06-08 KR KR1020067027912A patent/KR101221640B1/ko not_active Expired - Fee Related
- 2005-06-08 RS RS20110434A patent/RS52038B/sr unknown
- 2005-06-08 EP EP05761294A patent/EP1773451B1/en not_active Expired - Lifetime
- 2005-06-08 HR HR20110718T patent/HRP20110718T1/hr unknown
- 2005-06-13 AR ARP050102379A patent/AR049220A1/es unknown
-
2011
- 2011-11-14 CY CY20111101092T patent/CY1112032T1/el unknown
-
2014
- 2014-08-15 JP JP2014165542A patent/JP2014231518A/ja active Pending
-
2015
- 2015-07-13 HK HK15106661.8A patent/HK1205951A1/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003503454A5 (enExample) | ||
| CA3094580C (en) | Oral formulations of cytidine analogs and methods of use thereof | |
| JP2009502743A5 (enExample) | ||
| CY2016031I1 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
| IS8398A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
| IL167900A (en) | Use of betamimetics to prepare a medical preparation for the treatment of chronic obstructive pulmonary disease | |
| WO2009049184A9 (en) | Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors | |
| CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
| WO2007107305A3 (en) | Treatment of triple receptor negative breast cancer | |
| WO2006082523A3 (en) | Pharmaceutical sustained release composition of metformin | |
| AP2378A (en) | Sulfonamide derivatives for the treatment of diseases. | |
| CL2006002831A1 (es) | Compuestos derivados de sulfonamida: proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad mediada por el receptor de glucocorticoides. | |
| IL164896A (en) | Pharmaceutical compositions comprising immunoconjugates for the treatment of tumors | |
| WO2011012322A3 (en) | Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms | |
| IL188643A (en) | Derivatives – n (troaryl) –1 – troarylalkyl – 1h – indole – 2– carboxamide, process for the production of derivatives, drug, pharmaceutical composition and use of derivatives for drug production. | |
| AP2359A (en) | Sulfonamide derivatives for the treatment of diseases. | |
| CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
| WO2009071690A3 (de) | 5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen | |
| CL2007002919A1 (es) | Compuestos derivados de pirido[2,3-b]indol, inhibidores de quinasa; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar cancer, entre otras enfermedades. | |
| JP2007520565A5 (enExample) | ||
| CL2007001517A1 (es) | Compuestos derivados de carboxamida; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, en terapia de trastornos gastrointestinales funcionales, sindrome del intestino irritable, cancer, parkinson, alzheimer, desordenes cardiovasculares. | |
| IL187575A (en) | Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders | |
| PL394600A1 (pl) | Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna | |
| JP2015507020A5 (enExample) | ||
| TWI365741B (en) | Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation |